Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanglaite Injection plus Gemzar vs Gemzar in Advanced Pancreatic Cancer
ChiCTR-TRC-10000958Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in pancreatic cancer (PC) comparing Kanglaite Injection + Gemzar with Gemzar alone (2 arms). Primary endpoint: Time to Progression. Started Apr 2006; status: completed.
02
Drugs
kanglaitegemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on ChiCTR-TRC-10000958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000958.